BIIB

HOLD

Biogen Inc.

Healthcare · Rank #104 · Analyzed Jul 13, 2026

$199.15

Current Price

$763.42

Intrinsic Value

low confidence

Upside/Downside

4/10

Score

3/5

Quality

Analysis Summary

Valuation Consensus2/3 methods agree

Quality Score3/5.0

Framework RatingHOLD

Price vs Intrinsic ValueLow confidence — see rating

Fair Value Range

Low$14.02

Base (IV)$763.42

High$1065.26

Entry Points

Conservative$9.81

Moderate$14.02

Aggressive$534.39

⚠️ Warnings

Extreme base-case upside (283%) — verify inputs before trusting

Quality & Moat Breakdown

Return on Equity7.7% → 0/1.0

Debt LevelD/E 35 → 0.5/1.0

Revenue QualityGrowth 2.7%, margin Δ-3.5% +recovery → 1.0/1.0

Moat Strength2.5/5 → 0.5/1.0

Profit Margins13.8% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.